source Post navigation SOUL: Oral Semaglutide Cuts MACE by 14% in People with Type 2 Diabetes – HCPLive Association of habitual glucosamine use with risk of microvascular complications among individuals with type 2 diabetes: a prospective cohort study in UK biobank – Nature